Physician profile
David H Simon
NPI 1780869578
$11,283.65
in general payments reported to CMS, 2019-2025
11 companies · $10K in 2025
The $10K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $139 · 2021: $243 · 2022: $14.94 · 2023: $26.00 · 2024: $505 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $771.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stability Biologics, LLC | $10,000.00 | 2025 | |
| Next Science LLC | $516.41 | 2024-2025 | Xperience, Blastx, Surgx |
| Abbott Laboratories | $182.61 | 2021 | |
| Wright Medical Technology, INC. | $175.47 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $140.10 | 2024-2025 | |
| Organogenesis INC. | $117.17 | 2020-2021 | |
| Advanced Oxygen Therapy INC. | $47.23 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Stryker Corporation | $28.34 | 2025 | Ortholoc 3di Crosscheck |
| Kerecis Limited | $28.00 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $26.00 | 2023 | |
| Smith+Nephew, INC. | $22.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.